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ABSTRACT Annexins constitute a family of calcium-dependent membrane-binding proteins and can be classiﬁed into two
groups, depending on the length of the N-terminal domain unique for each individual annexin. The N-terminal domain of annexin
A1 can adopt an a-helical conformation and has been implicated in mediating the membrane aggregation behavior of this protein.
Although the calcium-independent interaction of the annexin A1 N-terminal domain has been known for some time, there was no
structural information about the membrane interaction of this secondary membrane-binding site of annexin A1. This study used
circular dichroism spectroscopy to show that a rat annexin A1 N-terminal peptide possesses random coil structure in aqueous
buffer but ana-helical structure in the presence of small unilamellar vesicles. The binding of peptides tomembraneswas conﬁrmed
by surface pressure (Langmuir ﬁlm balance) measurements using phosphatidylcholine/phosphatidylserine monolayers, which
show a signiﬁcant increase after injection of rat annexin A1 N-terminal peptides. Lamellar neutron diffraction with human and rat
annexinA1N-terminal peptides reveals an intercalation of the helical peptideswith the phospholipid bilayer, with the helix axis lying
parallel to the surface of membrane. Our ﬁndings conﬁrm that phospholipid membranes assist the folding of the N-terminal
peptides into a-helical structures and that this conformation enables favorable direct interactions with the membrane. The results
are consistentwith the hypothesis that theN-terminal domain of annexinA1 can serve as a secondarymembranebinding site in the
process of membrane aggregation by providing a peripheral membrane anchor.
INTRODUCTION
Since the 1980s, annexins have been discovered in different
taxonomic kingdoms, with the best-studied subfamily being
the one from vertebrate animals, now designated annexin
group A. Members of this protein family are involved in mem-
brane trafficking and reorganization as well as in processes
such as endo-, exo-, and phagocytosis (1,2).
Annexins are ubiquitous in cytosolic proteins, and their
members share the property of calcium-dependent binding to
membranes containing negatively charged phospholipids
(3–6), which underpins their biological functions on the
cytoplasmic leaflet of membranes where acidic phospholipids
are enriched. Annexins are furthermore involved in the cal-
cium-dependent organization of the cytoskeleton (7) andmem-
brane microdomains (rafts) (8). In the sarcolemma of smooth
muscle cells, annexin A2 can promote clustering of phos-
pholipids, stabilize lipid rafts, and thus regulate transmem-
brane signal transduction (9).
Calcium ions are coordinated in type II (10,11) or type III
(12) binding sites. The bound calcium ions in type II and type
III binding sites serve as a bridge to enable annexin interactions
with phospholipid membranes (13,14). The circular array of
four repeats yields the shape of a curved disk for the C-terminal
domain. The N-terminal domain is located on the concave side
of annexins and varies in length and sequence. It is thus
believed to confer specific properties on an individual annexin.
A comparison of the length of the N-terminal regions reveals
three main groups: between 11 and 19 residues (annexins A3,
A4, A5, A6, A10, A12, A13), between 33 and 42 residues
(annexins A2 and A1, respectively), and more than 100
residues (annexins A7 and A11). Annexins with considerably
longer N-terminal domains have been shown to harbor dif-
ferent phosphorylation sites for serine/threonine and tyrosine-
specific kinases as well as binding sites for S100 proteins, e.g.,
annexinA1, S100A11 (15,16); annexinA2, S100A10 (17); and
annexin A11, S100A6 (18).
Annexin A1 is of pharmaceutical interest because it is up-
regulated by antiinflammatory glucocorticoids and func-
tions as a cellular mediator of glucocorticoids (19). Previous
studies have shown that annexin A1 can interact with the
phospholipid monolayer in the absence of calcium under
acidic conditions (20). Whereas annexin A1, but not annexin
A5, was found to aggregate neutrophil and chromaffin cell
granules (21,22) as well as phospholipid vesicles (23), a
chimera protein with the annexin A1 N-terminal domain
fused to the annexin A5 C-terminal domain restored the
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aggregation behavior (24). It has thus been concluded that
the N-terminal domain of annexin A1 can interact with
membranes independently of the canonical annexin mem-
brane binding at the convex surface (25,26). This hypothesis
is further supported by the finding that endosome association
of annexin A1 requires an intact N-terminal domain (27) as
well as the results from a vesicle aggregation study using
various annexin A1 truncation mutants (28).
Despite the established involvement of the N-terminal
domain, the molecular mechanisms of annexin A1-induced
membrane aggregation remain unclear. Two models have
been suggested. The first model assumes membrane aggre-
gation is conducted simultaneously by two membrane
binding sites on one annexin molecule (21,24,29,30). The
second model suggests that an annexin-annexin complex
linked via the N-terminal tails or other binding partners, such
as S100 proteins, promotes aggregation of two opposite
membranes (16,21,29,31).
The crystal structures of full-length annexin A1 in the
absence (32) and presence (33) of calcium suggest a calcium-
dependent relocation of the N-terminal tail. In the apo-form
(32), the N-terminal 26 amino acids fold into two a-helices
with a tilt at Glu-17 and insert into the third repeat of the
C-terminal domain. Residues 2–12 adopt an amphipathic
conformation. The amphipathic character of the N-terminal
helix suggests a direct interaction of the N-terminal domain
with membrane, possibly by annealing to the lipid surface.
In the crystal structure of the calcium-bound form (33), the
N-terminal domain was not found in its previous position,
i.e., expelled from the third domain. Although the electron
density of residues 1–40 could not be resolved, presumably
because of the high flexibility of this region, a previous NMR
and CD study (34) reported a helical conformation of human
annexin A1(2–26) in membrane-mimetic environments.
In this study, we investigate the folding properties and
membrane bindingbehavior of annexinA1N-terminal peptides.
Using CD spectroscopy, we find that the presence of phospho-
lipid vesicles induces an a-helical fold in the rat N-terminal
peptide. Calcium-independent interactions of the peptides
with membrane monolayers were confirmed with surface film
balance measurements. The membrane-binding mode was
characterized at the molecular level using neutron diffraction
and revealed a parallel orientation of the peptides lying on the
surface of membrane. Therefore, the N-terminal domain may
serve as a secondary membrane binding site in the process of
membrane aggregation. These data support a model of annexin
A1-induced membrane aggregation where the protein interacts
with two adjacent membrane surfaces simultaneously.
MATERIALS AND METHODS
Proteins and peptides
The cDNA for annexin A1 was kindly provided by Joannes Sri Widada (see
35). Annexin A1 cloned into pKK233-2 was expressed in Escherichia coli
JM109. The chimera annexin A1N-A5C was subcloned from pGEXT2T (36)
into pRSET_6c (NdeI/BamHI). Annexin A5 in pRSET_5d, as well as the
chimera, were expressed in E. coli BL21(DE3). For all proteins, a total of 8
liters of LBmedium (50mg/ml ampicillin) were inoculated with an overnight
culture of 1 liter. The cells were grown at 37Cuntil theOD at 600 nm reached
1.0. Induction was carried out with 0.5 mM isopropyl thio-b-D-galactoside;
at that time, the ampicillin concentration was increased twofold, and the
temperature was reduced to 30C. Protein expression proceeded overnight.
Purification of annexin A1 followed the procedure published by Sri
Widada and associates (35) with minor modifications. Annexin A5 and the
chimera were purified based on the protocol by Burger (37) with minor
modifications (38,39). After harvest, cells were lysed bymultiple freeze-thaw
cycles and subsequent sonication. The resulting suspension was cleared by
ultracentrifugation (100,0003 g, 30min, 4C), and the cytosolic fractionwas
used for further purification. Annexin A1 was subjected to anion-exchange
chromatography with Q-Sepharose; appropriate fractions were pooled and
dialyzed against 100 mM NaCl, 2 mM CaCl2, 20 mM TRIS (pH ¼ 8.0).
Further purification made use of the calcium-dependent lectin behavior of the
protein. The solution was loaded onto heparin Sepharose, and annexin A1
eluted with 4 mM EDTA after extensive washing (2 mM CaCl2).
Annexin A5 and the chimera were purified by calcium-dependent
binding to liposomes made from soy lipid extract (Lipid Products, Surrey,
UK). Briefly, the cytosolic fraction from the ultracentrifugation step was
mixed with the liposome suspension, and the calcium concentration was
adjusted to 5 mM. Subsequent wash and desorption steps involved several
rounds of ultracentrifugation at 5 mM CaCl2, 10 mM EDTA, and 10 mM
EDTA/CHELEX. The semipurified annexins were subjected to final anion
exchange chromatography with Q-Sepharose.
The peptides (Fig. 1) containing the human annexin A1 sequence were
synthesized by Neosystem Laboratory, Strasburg, France. The peptides
containing the rat sequences were synthesized by the Advanced Biotech-
nology Centre Imperial College, London, UK.
Preparation of vesicles
Multilamellar vesicles (MLVs) were prepared following the method of
Szoka and Papahadjopoulos (40). Appropriate amounts of pure lipid or lipid
mixtures were dissolved in chloroform/methanol (2:1, v/v) followed by
evaporation using a nitrogen gas stream. The dry lipid film was deposited
under a vacuum system for 12 h to remove the residual organic solvents. The
appropriate aqueous buffer was then added to resuspend the dry lipid film by
vigorous vortexing and left to settle for 30 min. Throughout the entire
process, the temperature of the mixture was maintained above the transition
temperature of the lipids.
Dispersion of MLVs using sonication yields small unilamellar vesicles
(SUVs) with diameters ranging from 15 to 50 nm. The SUV preparation
procedure was modified from Pagano and Weinstein (41). Appropriate
amounts of dimyristoyl-phosphatidylcholine (DMPC) and dimyristoyl-
phosphatidylserine (DMPS) in a molar ratio of 3:1 were loaded in a round-
bottom test tube and dissolved thoroughly in chloroform/methanol (2:1, v/v).
A sample of MLVs with a final phospholipid concentration of 10 mg/ml
was prepared according to the procedure above, and a temperature of 35C
was maintained throughout. Subsequently, bath sonication was performed to
disperse the MLVs and convert to SUVs. Sonication was performed at 4C
under nitrogen to avoid oxidative degradation of the phospholipids. SUV
formation was considered to be completed when the suspension adopted a
clear bluish color.
Circular dichroism spectroscopy
For CD measurements, annexin A1 N-terminal peptides were dissolved in
buffer consisting of 10 mM NaH2PO4 (pH ¼ 6.2) at a final concentration of
0.08 mg/ml. DMPC/DMPS (3:1 molar ratio) SUVs were added to the
peptide solution at a molar ratio of n(phospholipid):n(peptide) ¼ 100:1. All
sample spectra were corrected by subtracting buffer/SUV-only spectra of
1774 Hu et al.
Biophysical Journal 94(5) 1773–1781
samples containing no peptide. Baseline subtraction and secondary structure
prediction were carried out using the program ACDP (42,43).
Monolayer surface pressure measurements
Kinetic studies of peptide adsorption to phospholipid monolayers were
carried out on a computer-controlled Langmuir film balance (NIMA) at
20C. The area of the Teflon trough was 300 cm2 (30 cm 3 10 cm), and it
was equipped with a movable barrier that allowed the adjustment of the
surface area of the monolayer. The subphase buffer containing 100 mM
NaCl and 20 mMMES (pH¼ 6.0) was filtered with Whatman 0.1- mm filter
paper and poured into the trough until the surface was 2 mm higher than the
trough brim (210 ml). The surface of the buffer was separated by the
movable barrier into two isolated areas. For optimal circulation and mixture,
an extra stirrer made of Teflon, rotating at 6 rpm, was applied in the
compartment where no phospholipids were added. The surface pressure was
measured with a surface potential meter using 1 cm3 2.3 cm plates cut from
filter paper (Whatman, No. 1). The lipid suspension was prepared as a
mixture of DMPC and DMPS (3:1 molar ratio) dissolved in chloroform/
methanol (2:1, v/v) at a concentration of 1 mg/ml, and 30 ml of this
suspension was applied onto the surface of the subphase with a Hamilton
syringe. After spreading, the monolayer was left to equilibrate for 20 min.
The film was compressed by moving the barrier to generate a surface
pressure of 10 mN/m, a value that is thought to mimic the biological
membrane condition (20,44). After 5 min of further equilibration, peptides
or proteins were injected into the subphase to a final concentration of 30 nM,
using a Hamilton syringe extending beneath the barrier. The surface pressure
(mN/m) against time (s) was recorded until no further increase was observed.
Neutron diffraction
Sample preparation and data collection
Multiple bilayers of phospholipids and peptides were prepared following a
published protocol (45,46): 20 mg of a DMPC/DMPSmixture (3:1 molar ratio)
were codissolved with 1 mol % peptide in chloroform:methanol (2:1, v/v).
The solution was airbrushed onto quartz microscope slides using nitrogen as
the propellant. The slides were placed under vacuum for 12 h to remove the
organic solvent and the samples rehydrated in sealed sample cans for 12 h at
30C to achieve full equilibration. The relative humidity inside the sample
cans was adjusted to 85%, 90%, or 95% by changing the temperature of the
water bath. The 2H2O concentration was set to 8% (v/v) for each relative
humidity. An extra condition was prepared with 50% (v/v) 2H2O at 90%
relative humidity. Diffraction data sets consisting of five orders of diffraction
were collected for each of the four conditions, using the D16 membrane
diffractometer instruments at the Institut Laue-Langevin, Grenoble, France.
The scanning protocol consisted of u–2u scans at 62 around the predicted
Bragg angle of the first five orders of diffraction.
Data analysis
The diffraction intensity was obtained from the detector counts according to
the pixel response, and the diffraction images were then collapsed into a
linear spectrum for each scan using D16 instrument software Lamp (47).
Baseline correction and peak fitting based on the Lorentz function were
performed using PeakFit (AISN Software). The diffraction angles and
intensities determined by the peak fitting were then transferred into Excel
(Microsoft) spreadsheets for geometric correction. The data collected at 8%
FIGURE 1 (a) Peptides used within this study. Helical
wheel representation of the N-terminal domains of (b)
human and (c) rat annexin A1 showing the amphipathic
character of the a-helix. The horizontal lines indicate the
separation of hydrophobic (down) and hydrophilic (up)
faces. The diagrams are produced with WinPep v3.01 (65).
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2H2O were combined to construct a continuous transform function, from
which sets of structure factors were extracted to be used in the calculation of
neutron- scattering density maps. Each map, representing a one-dimensional
bilayer profile, was constructed using Fourier summation in which the
diffraction data of each order contribute a frequency cosine function. The
square roots of the intensities were taken to produce the structure factor
amplitudes. Because the net neutron scattering length density of water
containing 8% deuterium is zero, a single continuous transform function fits
all structure factors collected with water of this composition, no matter what
the d-repeat spacing. All structure factors collected at 8% 2H2O data were
plotted, and the phase angles for each diffraction order were adjusted to
allow the observed points of the three data sets to fit a single continuous
transformation, using a least-squares minimization procedure (45). Water
profiles of the stacked bilayer systems were calculated by subtracting the
scattering profile at 8% 2H2O from the profile at 50%
2H2O. Scaling of the
individual data sets to each other was performed using an absolute scale
based on the neutron- scattering lengths of known component molecules,
i.e., phospholipids.
RESULTS
Circular dichroism spectroscopy
To investigate the folding of the N-terminal domain of annexin
A1 in the absence and presence of vesicles, the secondary
structure of rat annexin A1(2–26) peptide was assessed using
CD spectroscopy with/without unilamellar DMPC/DMPS
vesicles (3:1 molar ratio) at 20C (Fig. 2). In aqueous buffer,
the CD spectrum of rat annexin A1(2–26) displayed a typical
spectrum characteristic for predominantly random-coil con-
formation. However, in the presence of SUVs, the CD spec-
trum revealed a maximum at 190 nm and two minima at 208
and 222 nm, which is a typical spectrum for a-helical con-
formation. Secondary structure prediction indicates a 58%
increase ina-helix structure. These results demonstrate that the
association of the peptide with phospholipid vesicles induces
formation of helical structure in the peptide.
Lateral surface pressure measurement
We used a surface film balance with Langmuir Blodgett
phospholipid monolayers to monitor the binding kinetics of
annexin proteins and A1 N-terminal peptides in the absence of
calcium. Basically, both transmembrane domains (48) and
amphipathic helices (49) of proteins would cause an increase in
surface pressure of phospholipid monolayer because a substan-
tial area of phospholipids on the water surface is occupied by
the inserted side chains. The surface pressure of DMPC/DMPS
monolayers (3:1 molar ratio) after injection of full-length
proteins or peptides was recorded as a function of time. As seen
in Fig. 3 a, full-length human annexin A1 induced a dramatic
surface pressure increase of 3 mN/m in the initial 200 s. This
result agrees with a previous study, which also demonstrated
that the calcium-independent interaction of annexinA1 is based
on hydrophobic interactions and independent of the charge of
the phospholipid headgroups (20).As expected, human annexin
A5 lacking the membrane-binding function in its N-terminal
domain showed no monolayer penetration ability. Chimera
annexin A1N-A5C also gave rise to an increase in surface
pressure, although to a lesser extent than annexin A1 (;2 mN/
m). The increase in surface pressure seen with the chimera, but
not with annexin A5, provides further proof that the N-terminal
FIGURE 2 CD spectra of rat annexin A1(2–26) in the absence (solid line)
and presence (dashed line) of DMPC/DMPS (3:1 molar ratio) SUVs.
FIGURE 3 Phospholipid monolayer surface pressure measurements after
injection of (a) full-length human annexin proteins: annexin A1 (solid line),
annexin A5 (dash-dotted line), and chimera protein annexin A1N-A5C
(dashed line), and (b) rat annexin A1 N-terminal peptides (1–50)-S27A
(dashed line), (1–50)-S45A (dotted line), and (2–26) (solid line) in the
absence of calcium. Baseline traces acquired in the absence of peptides or
proteins have been subtracted.
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domain of annexin A1 exerts independent membrane interac-
tions, although annexin A5 seems to have a low monolayer
penetration ability, most likely because of nonspecific
electrostatic interactions. The difference in the surface
pressure curves of annexin A1 and the chimera indicates
that the C-terminal domain affects the overall membrane
association of the full-length proteins, probably by structur-
ally stabilizing the conformation of the N-terminal domain in
a way that would enable productive membrane interactions.
However, eventual calcium-independent interactions of the
C-terminal domain of annexin A1 with the monolayer cannot
be excluded by our current results.
To validate the function of isolated N-terminal domains in
monolayer association, several rat annexin A1 peptides also
were subjected to surface pressure measurements in the
absence of calcium (Fig. 3 b). The rat peptides (1–50)-S27A
and (1–50)-S45A revealed similar levels of surface pressure
increase when compared with full-length annexin A1 and the
chimera for the entire time course of ;2000 s (;3 mN/m).
The slightly slower time course of adsorption to the mono-
layer in the case of (1–50)-S27A might be explained by the
stabilizing effect of Ser-27 on the preceding helical structure.
Situated at the cap of the a-helix, the side-chain hydroxyl
group of Ser-27 is likely to interact with a backbone carbonyl
group of the a-helix, similar to the situation observed in
porcine full-length annexin A1 (1hm6) where Ser-28-OH is
hydrogen-bonded to the carbonyl group of Val-25. Such an
interaction would be lacking in (1–50)-S27A and thus yield
a less stable a-helical structure because of the higher
flexibility of the cap, which could explain the slower
adsorption process.
A surface pressure increase of rat annexin A1(2–26) was
also observed, but with;2 mN/m less intensity than with the
other two mutant peptides. The difference in surface pressure
increase of this peptide as compared with the longer peptides
(residues 1–50) is most likely caused by additional interac-
tions with the monolayer by residues 27–50.
Neutron diffraction
The lamellar spacings (d-repeats) of the DMPC/DMPS (3:1
molar ratio) bilayer at 90% relative humidity were determined
by least- squares fitting to the five orders of neutron diffraction.
As shown in Table 1, the d-repeats do not change significantly
after addition of 1 mol % annexin A1 N-terminal peptides.
Furthermore, human and rat peptides reveal no significant dif-
ferences in lamellar spacings. The fact that the unit cell
dimension in the Z-direction does not change on addition of the
peptides rules out the possibility of superficial interaction of
peptide and lipid. These results suggest an insertion of the
annexin A1 N-terminal peptides into the phospholipid mono-
layer or accommodation of the peptides in the hydrophilic
spaces between the stacked bilayers: either the peptides lie
parallel to the bilayer surface (Fig. 4), or they insert vertically
into the bilayer.
Neutron structure factors for each order of diffraction have
been calculated and are shown in Table 2. From these, neutron-
scattering density profiles of the DMPC/DMPS bilayer, in the
presence or absence of the peptides,were calculated (Fig. 5).At
8% 2H2O composition, the mean neutron scattering length of
the water mixture is zero (50), so the water does not contribute
to the profiles shown. The trace shown with a solid line
represents the section of the neutron scattering length density
profile of the phospholipid bilayer along the Z-axis, perpen-
dicular to the surface of the lipid bilayer. The two maxima
of the profile arise from a combination of the phosphate-
containing head groups and the hydrogen-poor glycerol
groups, whereas the minimum in the center indicates the
hydrogen-rich methyl groups at the bilayer center. The short-
dashed trace, obtained by subtracting structure factors for lipid
bilayer- containing peptide from structure factors for pure lipid,
followed by Fourier transformation, describes the difference
profile of human annexin A1(1–21) (Fig. 5 a) and rat annexin
A1(2–26) (Fig. 5 b).
To obtain more quantitative measurements of the changes
induced by the annexin A1 N-terminal peptides in the bilayer
structure, the difference profiles were fitted to a single pair of
Gaussians. The fitting was carried out in reciprocal space to
avoid artifacts caused by series termination error. The fit
parameters are summarized in Table 3. It is noteworthy that,
in each case, the difference was adequately described by a
FIGURE 4 Incorporation of a helical peptide into a stacked bilayer system
can affect the d-repeat distance by altering the height of the bilayer water
layer. If the peptide lies along the bilayer surface (a), the water layer
becomes thicker because it now has to include the peptide and its hydration
shell. When the peptide lies deep in the bilayer (c), rearrangement of the
phospholipid molecules to incorporate the peptide can increase their hori-
zontal width, thereby decreasing their vertical height. If the d-repeat does not
change, this indicates that the peptide lies in the interfacial region (b), such
that any water layer thickening is compensated for by bilayer thinning.
TABLE 1 Lamellar spacings (d-repeats) of the DMPC/DMPS
(3:1 molar ratio) bilayer in the presence or absence of annexin
A1 N-terminal peptides
d-Repeat (A˚)
DMPC/DMPS 54.45
DMPC/DMPS 1 1 mol % human annexin A1(1–21) 54.52
DMPC/DMPS 1 1 mol % rat annexin A1(2–26) 54.45
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single pair of Gaussians, indicating that the minor peaks
located at the bilayer center are artifacts, produced by
termination error. Each of the peptides appears at the
interface of the phospholipid head groups and alkyl chains,
the narrow width suggesting a parallel orientation relative to
the bilayer surface. The Gaussian peaks characterizing the
human and rat peptides are positioned at 19.05 A˚ and 19.36
A˚, respectively, very close to the maxima representing the
head groups and glycerol groups of the phospholipids.
The water distribution in the stacked bilayer system was
obtained by subtracting the scattering profile at 8% 2H2O
from that at 25% 2H2O sample hydration. Fig. 6 shows the
water distribution profiles in the pure lipid bilayer as well
as in the presence of the human and rat peptides. The split
peaks at the ends of the figure (can be seen as a single peak
for continuous extension of unit cells) represent the water
between two adjacent lipid bilayers. The three difference
profiles are very similar to each other, apart from minor
features in the lipid core region in the two peptide-containing
samples. To validate the profiles, Gaussian peaks were fitted
in reciprocal space. The results, shown in Table 4, clearly
indicate that the features at;11 A˚ are real, although a minor
component exists, accounting for only 1–1.5% of the total
water. The peak located at the bilayer center (at Z ¼ 0) does
not fit to a Gaussian (in reciprocal-space fitting), indicating
that it results from termination error. The minor peaks are
readily explained in terms of exchanged protons on the
hydrophobic surface of the amphipathic a-helix bound
parallel to the bilayer surface and the deuterium atoms on
the hydrophobic face caused by hydrogen/deuterium ex-
change from solvent leading to higher scattering length
(51,52). Most importantly, the minor peaks shown here
cannot be explained by a transmembrane model in which the
peptide forms a channel-like structure lying perpendicular to
the bilayer and 2H2O diffusing freely through the bilayer (53).
The perpendicular insertion model should appear as a con-
tinuous bulge across the bilayer.
With the data from Tables 3 and 4 and the bilayer center
taken as the origin, a straightforward calculation shows that the
FIGURE 5 Neutron- scattering profiles of DMPC/DMPS (3:1 molar ratio)
in the presence of 1% (a) human annexin A1(1–21) and (b) rat annexin
A1(2–26) peptides. Experiments were carried out in 8% 2H2O, at 92%
relative humidity. A pair of lipid molecules at the bottom is shown for
orientation.
TABLE 2 Neutron structure factors F(h) of the annexin A1
N-terminal peptides in the bilayer DMPC/DMPS (3:1 molar ratio)
F(1) F(2) F(3) F(4) F(5)
DMPC/DMPS –20.59 –5.76 8.68 –6.04 –2.14
DMPC/DMPS 1 human
annexin A1(1–21)
–22.83 –6.31 10.56 –5.89 –1.98
DMPC/DMPS 1 rat
annexin A1(2–26)
–22.96 –6.38 10.17 –6.91 –2.50
h stands for the diffraction order. Data were collected at 90% relative
humidity, 8% 2H2O, 26C.
TABLE 3 Parameters of the Gaussian ﬁts of the peptide
difference proﬁles in reciprocal space
Scattering
length (1013 cm) Position (A˚) Width (A˚)
Human annexin A1(1–21) 1.24 19.05 9.42
Rat annexin A1(2–26) 1.29 19.36 8.56
The position is expressed as the distance from the center of the bilayer.
Width is the full width at half height of the fitted Gaussian distribution.
FIGURE 6 Water distribution profiles of DMPC/DMPS (3:1 molar ratio)
in the absence (solid line) and presence of human annexin A1(1–21) (dashed
line) and rat annexin A1(2–26) (dotted line).
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peptide peaks (full width at half height) span from 14.34 to
23.76 A˚ (human peptide) and 15.08 to 23.64 A˚ (rat peptide).
Similarly, the inner edges of water at half height lie at 21.46 A˚
(human peptide) and 20.63 A˚ (rat peptide). This means that
each of the peptides lies in a region of steep hydrophobic
gradient, ranging from the alkyl chains to the solvated head
groups, similar to other amphipathic a-helical peptides
(54,55). Although the outer edge of each peptide is positioned
at a similar depth in the bilayer (23.76 A˚ and 23.64 A˚ for human
and rat peptide, respectively), it should be noted that the full
width of human annexin A1(1–21) (9.42 A˚) is larger than that
of rat annexin A1(2–26) (8.56 A˚). The x-ray structure of
porcine annexin A1 in the absence of calcium (32) shows that
the N-terminal helical domain has a kink at Glu-17. Human
annexin A1(1–21) has an identical amino acid sequence
compared with the porcine ortholog, except for residue 17
being an aspartate. If it is assumed that the human peptide
adopts a similar conformation to the porcine protein, then this
would explain its greater width in neutron scattering profiles.
DISCUSSION
Previous studies showed that the N-terminal domain of some
annexins can adopt an a-helical conformation, and the helices
seem to have amphipathic character. The crystal structure of
human annexin A1(2–15) in complex with the E-F hand
protein S100A11 revealed an amphipathic helix for the peptide
in which the hydrophobic residues are buried within the
complex and in contact with the C-terminal helix of S100A11
(56). In contrast, the hydrophilic residues are involved in the
hydrogen bond with the N-terminal helix of S100A11.
NMR and CD studies demonstrated that Val-4 to Glu-19 of
human annexin A1(2–26) peptide adopt a mainly a-helical
conformation inmembrane-mimic systems (34). Intriguingly,
the induction of a-helical secondary structure on addition of
TFE has also been observed with human annexin A2(1–31)
(57). However, detailed molecular information about the
interaction of the annexin N-terminal domains with mem-
branes remains unclear so far.
Results from our CD experiments show that a-helical
secondary structure is induced in annexin A1 N-terminal
peptide (residues 2–26) in the presence of phospholipid
membrane, which agrees very well with previously published
studies. Together, these results suggest that the N-terminal
domain of annexin A1 retains the structure of an amphipathic
a-helix when expelled from the C-terminal domain and
interacting with a membrane.
The monolayer lateral surface pressure measurements of
full-length annexinsA1 andA5 are in excellent agreementwith
previous studies (20) and, together with the data for the A1N-
A5C chimera, confirm that the calcium-independentmembrane
interaction of annexin A1 is caused by the properties of its
N-terminal domain. The N-terminal domains of rat and human
annexin A1 share 80% similarity and have been shown to be
able to cause liposome aggregation (27). The two mutant
peptides S27A and S45A were originally synthesized to block
the phosphorylation sites on the N-terminal domain. The
results shown here demonstrate that all three peptides are able
to interact with the membrane directly, independent of calcium
ions. Although annexins generally require acidic phospho-
lipids for their canonical membrane binding, the secondary
membrane binding site of annexin A1 shows no such
preference (24,25). The pI values for rat annexin A1(2–26),
(1–50)-S27A, and (1–50)-S45A are 4.7, 4.8, and 4.8, respec-
tively. Under the experimental conditions of pH 6, the peptides
thus possess negative charge but still associate with the PS-
containing phospholipidmixture. It can therefore be concluded
that the interactions are hydrophobic rather than electrostatic,
which agrees with the parallel arrangement of an amphipathic
helix to the membrane bilayer surface.
Structural details of the membrane-bound state of annexin
A1 N-terminal peptides were obtained in this study by
neutron diffraction using multiple membrane bilayer stacks.
The results unambiguously showed that the peptides adopt a
peripheral mode of binding and are oriented parallel to the
membrane surface. The diffraction experiments were ana-
lyzed as to the difference scattering density profiles as well as
the water distribution in the stacked bilayer system. The
scattering density profiles obtained for the peptides, as well
as the water distribution, showed no sign of any additional
component appearing in the inner regions of the bilayer.
An increase in surface pressure of lipid monolayers is
generally interpreted as a penetration of themembrane surface
(59). Calculation of the axial location of themembrane-bound
peptides from the scattering profiles reveals that the peptides
extend from the alkyl chains to the solvated head groups of
the phospholipid molecules. Accordingly, the membrane-
adjacent side chains of the annealed a-helix insert into the
membrane surface region, thus providing an explanation for
the increase in surface pressure.
Clarification of the membrane aggregation mechanism of
annexin A1will depend on the structural information about the
membrane-bound state of the full-length protein. However, in
the absence of such data, it seems reasonable, based on the
current knowledge, to assume that the isolated N-terminal
peptides show a similar behavior as when covalently attached
TABLE 4 Parameters of the Gaussian ﬁts of the water
distribution in reciprocal space
Scattering
length (1013 cm) Position (A˚) Width (A˚)
Pure lipid 2.35 25.17 7.06
Human annexin A1(1–21)
1st Gaussian 2.75 25.05 7.18
2nd Gaussian 0.37 11.64 5.46
Rat annexin A1(2–26)
1st Gaussian 2.46 24.76 8.26
2nd Gaussian 0.25 10.66 5.32
The position is expressed as the distance from the center of the bilayer.
Width is the full width at half height of the fitted Gaussian distribution.
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to the C-terminal domain. Based on this assumption, the
current results put further weight on the notion that the annexin
A1 membrane aggregation mechanism, under the environ-
mental parameters of this study, involves two simultaneous
binding sites on one annexin molecule: the canonical calcium-
dependent binding via the convex surface and the calcium-
independent binding via the membrane-intercalated a-helical
N-terminal domain. A further interesting problem in this
context is the conformational state of the N-terminal domain of
annexin A1 during the relocation process from the protein-
harbored conformation to the membrane-associated state.
The previously published concept of amphitropism de-
scribes the phenomenon of a protein localizing to an aqueous
compartment in one form and reversibly attaching to a
membrane in another form (60). In this concept, annexin A1
fits well within one class together with proteins such as
cytidyltransferase, factor VIII, vinculin, and others (61). All
these proteins share the common feature of responding to an
increase in negative charge density at the membrane, and for
some of them, sensitivity to membrane curvature and packing
pressure has been implicated. Intriguingly, an implication of
annexins in membrane curvature has been reported earlier
(62), and recent studies about annexin B12 (63) seem to bring
this link back into focus. However, contributions by differ-
ent membrane binding sites, as are likely to be the case for
annexin A1, need to be clearly distinguished.
Our current results support the fundamental importance of
the annexin A1 N-terminal domain for membrane associa-
tion as shown by immunofluorescence (64), although the
effect of phosphorylation on the molecular mechanism of
the annexin A1 N-terminal domain remains to be elucidated
in more detail. Further studies elucidating the structure of
membrane-bound full-length annexin A1 will be required to
validate and extend the current hypothesis and are currently
under way in our laboratories.
CONCLUSION
Results from the current study support the hypothesis that
annexin A1 might interact with two adjacent membranes
simultaneously. Using N-terminal peptides of annexin A1,
we have been able to show that an a-helical secondary struc-
ture is induced by the binding of the peptides to phospholipid
membranes. Structural information from neutron scattering
enabled us to determine the location of the peptides in the
membrane-bound state. The peptides form an amphipathic
helix where some side chains intercalate with the phospho-
lipids, and the helix axis lies parallel to the membrane surface.
A.H. gratefully acknowledges partial support of this study by the Royal
Society (London) and the European League Against Rheumatism (EULAR).
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